Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2005
11/24/2005US20050261279 antipsychotic agents; phenylsulfonyl compounds; 7-Methoxy-8-(3-phenoxy-benzenesulfonyl)-2,3,4,5-tetrahydro-1H-3-benzazepine; schizophrenia
11/24/2005US20050261269 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
11/24/2005US20050261248 New-4-pyrrolopyrimidin-6-YL)benzenesulphonamide derivatives
11/24/2005US20050260601 Recombinant mutants of rhabdovirus and methods of use thereof
11/24/2005US20050260544 Novel device
11/24/2005US20050260230 Leucine-based motifs and enhanced biological persistence of clostridial neurotoxins
11/24/2005US20050260228 Vaccines absorbable by the transmucosal way
11/24/2005US20050260223 Salmonella vaccine materials and methods
11/24/2005US20050260192 Leukocyte function associated antigens comprising integrin I-domain for use in identifying modulators for prevention and treatment of inflammatory disorders; immunosuppressive agents
11/24/2005US20050260174 Systems and methods for treating patients with processed lipoaspirate cells
11/24/2005CA2566821A1 7-substituted benzimidazoles and their use as inhibitors of gastric acid secretion
11/24/2005CA2566408A1 Composition, comprising hydrofluoric acid, for inhibiting dental erosion
11/24/2005CA2565168A1 Stable pharmaceutical composition containing benzimidazole derivatives and method of manufacturing the same
11/24/2005CA2565084A1 Use of sulglicotide for the treatement of mucositis
11/24/2005CA2507712A1 Pharmaceutical compounds
11/24/2005CA2507710A1 Tricyclic pyrazole derivatives and their use as cb1 or cb2 modulators
11/23/2005EP1598369A1 Antibody and use thereof
11/23/2005EP1598365A1 Protection of endogenous therapeutic peptides
11/23/2005EP1598347A1 Polymorphs of pantoprazole sodium salt and process for the preparation thereof
11/23/2005EP1598346A1 Process for producing acid adduct salt of polyacidic base compound
11/23/2005EP1598077A1 Use of the neurotoxic component of botulinum toxins for the treatment of a spastic muscle
11/23/2005EP1598072A1 Medical drug containing fine particle of noble metal
11/23/2005EP1597587A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a)
11/23/2005EP1596862A1 Use of palonosetron treating post-operative nausea and vomiting
11/23/2005EP1596856A2 Drugs containing substituted 2-aryl-aminoacetic acid compounds and/or substituted 2-heteroaryl-aminoacetic acid compounds
11/23/2005EP1596844A2 Use of sodium channel modulators for treating gastrointestinal tract disorders
11/23/2005EP1596812A2 Bioadhesive liquid composition which is substantially free of water
11/23/2005EP1596810A2 Treatment of inflammatory bowel disease
11/23/2005EP1446015A4 Remodeling of tissues and organs
11/23/2005EP1377550B9 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
11/23/2005EP1280777B1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/23/2005EP1267846B1 Transdermal therapeutic system for the delivery of lerisetron
11/23/2005EP1135098B1 Methods of reducing the astringency of stannous in dentifrice compositions
11/23/2005EP1066261B1 Pyridine derivative and pharmaceutical containing the same
11/23/2005EP0837939B1 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
11/23/2005EP0770129B1 Zinc finger protein derivatives and methods therefor
11/23/2005CN1701116A Probiotic bacterium: lactobacillus fermentum
11/23/2005CN1701068A Novel compounds and their use
11/23/2005CN1701061A New compounds for the inhibition of rotamases and use thereof
11/23/2005CN1700934A Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols
11/23/2005CN1700926A Composition containing beta-glucan and constipation-relieving drug, immunopotentiator and skin moistening agent using the composition
11/23/2005CN1700916A Use of HIV-protease inhibitors to block cell migration and/or invasion, tissue inflitration and oedema formation
11/23/2005CN1700914A The prevention and treatment for inflammatory disease in oral-cavity mucosa
11/23/2005CN1700912A Choline ascorbate formulations
11/23/2005CN1699385A Crystal form of adefovir dipivoxil
11/23/2005CN1699346A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
11/23/2005CN1698648A Montmorillonite dispersed tablet and preparation technique thereof
11/23/2005CN1698601A Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl iv, processes for their preparation, and their use
11/23/2005CN1228335C Crystal choline ascorbate
11/23/2005CN1228077C Chinese drugs for treating Hepatitis B and AIDS
11/23/2005CN1228073C Semen coicis-poria cocos capsule for stomachache
11/23/2005CN1228070C Red sage root-astragalus root particles for liver softening
11/23/2005CN1228066C Oral liquid of eighteen herb medicines for kidney-tonifying and qi replenishing and prepn. method thereof
11/23/2005CN1228063C Medicine for treating liver disease
11/23/2005CN1228062C Medicine for treating liver disease
11/23/2005CN1228058C Production method of medical healthcare beautifying product
11/23/2005CN1228057C Compound of solanesol and its preparing process
11/23/2005CN1227982C Plant nutritious tea for medicine and food and preparation method thereof
11/22/2005US6967207 Preventive or therapeutic agents for gastric or esophageal regurgitation
11/22/2005US6967200 Remedies for cirrhosis
11/22/2005US6967199 Substituted diamine derivatives useful as motilin antagonists
11/22/2005US6967197 Also used in production of tumor necrosis factor alpha
11/22/2005US6967023 solidifying agent consists of a long chain fatty alcohol having at least 15 carbon atoms in its backbone and a fatty acid having at least 18 carbons in its backbone; carrier is semi-solid at rest and liquefies upon application of shear forces
11/22/2005CA2277100C Cyclic sulfone derivatives
11/22/2005CA2258918C Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
11/22/2005CA2161683C Veterinary composition containing a proton pump inhibitor
11/17/2005WO2005108558A1 Method of inducing human pulp cell differentiation and composition for dentin regeneration
11/17/2005WO2005108400A1 Pyridoquinazoline derivatives having heterobicyclic substituents
11/17/2005WO2005108399A1 Imidazopyridine compound
11/17/2005WO2005108370A1 Benzene compounds
11/17/2005WO2005107783A1 Food containing extract from bark of pine
11/17/2005WO2005107778A1 Body fat reducing preparation
11/17/2005WO2005107769A1 Oral flora-improving agent, antibacterial agent and growth promoter
11/17/2005WO2005107737A1 Antifatigue composition
11/17/2005WO2005107731A1 Remedies containing vitamin k2 as the active ingredient
11/17/2005WO2005107498A1 Food containing polyphenol
11/17/2005WO2005107495A1 Mixed fruit concentrates against constipation and mehtod for preparation thereof
11/17/2005WO2004108945A3 Oligonucleotide modulation of cell adhesion
11/17/2005US20050256456 Apparatus for delivery of therapeutic and/or diagnostic agents
11/17/2005US20050256333 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis
11/17/2005US20050256315 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators
11/17/2005US20050256299 Vaccines
11/17/2005US20050256201 Phenethanolamine derivatives
11/17/2005US20050256171 Pyrrolidine derivatives as tryptase inhibitors
11/17/2005US20050256160 Beta-alanine derivatives and the use thereof
11/17/2005US20050256122 Substituted pyridazinones
11/17/2005US20050256108 avoid the adverse side effects associated with non-selective receptor interactions; 1-(4-Fluorobenzyl)-2-(4-methoxybenzyl)-8-methyl-1,2,8-triaza-spiro[4.5]decan-3-one; 1-oxa-4,9-diaza-spiro[5.5]undecan-3-one compounds as monoamine receptor modulators; schizophrenia, psychosis, migraine, hypertension
11/17/2005US20050255549 IRAK-4: compositions and methods of use
11/17/2005US20050255156 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
11/17/2005US20050255124 HCV E1E2 vaccine compositions
11/17/2005US20050255102 binds to alpha v beta 6 and not other alpha v integrins or non-specific integrins; inhibits the binding of alpha v beta 6 to latency associated peptide with an IC50 value lower than that of 10D5 and binds alpha v beta 6 in manner that does not distinguish between the use of Ca2+/Mg2+ and Mn2+ for cation
11/17/2005DE10392697T5 Herstellung und Standardisierung von immunmodulierenden Peptid-verknüpften Glucanen mit nachweisbarer oraler Resorbierbarkeit aus Coriolus Versicolor Preparation and standardization of immunomodulating peptide-linked glucans with detectable oral absorbability from Coriolus Versicolor
11/17/2005CA2566398A1 Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin
11/17/2005CA2566184A1 Imidazopyridine compound
11/17/2005CA2566083A1 Antifatigue composition
11/16/2005EP1595867A1 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient
11/16/2005EP1595539A1 Drug for reducing side effects in ribavirin interferon combination therapy
11/16/2005EP1594841A1 Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines
11/16/2005EP1594574A2 Nk1 receptor antagonists for the treatment of functional dyspepsia
11/16/2005EP1594517A2 Methods and compositions for the treatment of gastrointestinal disorders
1 ... 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 ... 1258